FDA awards humanitarian status to Exalenz's liver diagnostic tool

09/11/2011 | Globes (Israel)

Exalenz Bioscience has secured humanitarian device exemption status from the FDA for its BreathID device in the diagnosis of acute liver failure, shortening its process to FDA approval. The designation comes a week after the company received FDA approval for a clinical study designed to evaluate the efficacy of the device in detecting liver cancer at an early stage.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA